_id

690dad0eccc777a4e85d09dc

Ticker

ALEC

Name

Alector Inc

Exchange

NASDAQ

Address

131 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.alector.com

Description

Alector, Inc., a late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases. The company's products under development include Latozinemab (AL001), an investigational human recombinant monoclonal antibody designed to elevate progranulin (PGRN), a protein encoded by the granulin (GRN) gene that regulates lysosomal function, neuronal survival, and inflammation in the brain. Its lead PGRN-elevating candidate is being developed for the potential treatment of frontotemporal dementia with a granulin gene mutation (FTD-GRN) which is caused by heterozygous loss-of-function (LOF) mutations in the GRN gene and results in PGRN haploinsufficiency and is in Phase 3 clinical trial. It also develops AL101/GSK4527226 that is in Phase 2 clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. In addition, the company's preclinical and research pipeline products include ADP037-ABC, a proprietary anti-amyloid beta (Aß) antibody paired with proprietary ABC for the treatment of AD; ADP050-ABC, a GCase replacement therapy paired with proprietary ABC for GBA gene mutation carriers with Parkinson's disease and Lewy body dementia; ADP056, a Reelin modulator designed to block tau pathology and promote synaptic function in AD; and ADP063-ABC and ADP064-ABC that are therapeutic candidates paired with proprietary ABC that target tau pathology in AD through distinct approaches. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including latozinemab and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.

Last Close

1.46

Volume

1338791

Current Price

1.49

Change

2.054794520547947

Last Updated

2025-11-28T12:06:06.808Z

Image

data:image/webp;base64,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

Ipo Date

2019-02-07T00:00:00.000Z

Market Cap

147354496

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.3778333333333334

Sentiment Sources

6

Rating

3.8889

Target Price

2.05

Strong Buy

5

Buy

1

Hold

1

Sell

1

Strong Sell

1

Current Quarter

2025-09-30

Revenue

3260000

Cost Of Revenue

-

Gross Profit

3260000

Operating Expenses

40868000

Operating Income

-37608000

Interest Expense

-

Pretax Income

-34667000

Net Income

-34667000

Eps

-0.3378928908873805

Dividends Per Share

-

Shares Outstanding

109151472

Income Tax Expense

-

EBITDA

-33430000

Operating Margin

-1153.6196319018404

Total Other Income Expense Net

2941000

Cash

76503000

Short Term Investments

214605000

Receivables

-

Inventories

-

Total Current Assets

300385000

Property Plant Equipment

28583000

Total Assets

335285000

Payables

4757000

Short Term Debt

8979000

Long Term Debt

9611000

Total Liabilities

277573000

Equity

57712000

Depreciation

2332000

Change In Working Capital

-5105000

Cash From Operations

-32511000

Capital Expenditures

11000

Cash From Investing

49542000

Cash From Financing

14701000

Net Change In Cash

31732000

PE

-

PB

2.648849901060438

ROE

-60.06896312725256

ROA

-10.339561865278792

FCF

-32522000

Fcf Percent

-9.976073619631903

Piotroski FScore

1

Health Score

17

Deep Value Investing Score

3

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

1

Growth Investing Score

1

Momentum Investing Score

6

Net Net Investing Score

2

Quality Investing Score

1

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

3260000

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

3260000

Quarters > 0 > income Statement > operating Expenses

40868000

Quarters > 0 > income Statement > operating Income

-37608000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-34667000

Quarters > 0 > income Statement > net Income

-34667000

Quarters > 0 > income Statement > eps

-0.3378928908873805

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

102597601

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-33430000

Quarters > 0 > income Statement > operating Margin

-1153.6196319018404

Quarters > 0 > income Statement > total Other Income Expense Net

2941000

Quarters > 0 > balance Sheet > cash

76503000

Quarters > 0 > balance Sheet > short Term Investments

214605000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

300385000

Quarters > 0 > balance Sheet > property Plant Equipment

28583000

Quarters > 0 > balance Sheet > total Assets

335285000

Quarters > 0 > balance Sheet > payables

4757000

Quarters > 0 > balance Sheet > short Term Debt

8979000

Quarters > 0 > balance Sheet > long Term Debt

9611000

Quarters > 0 > balance Sheet > total Liabilities

277573000

Quarters > 0 > balance Sheet > equity

57712000

Quarters > 0 > cash Flow > net Income

-34667000

Quarters > 0 > cash Flow > depreciation

2332000

Quarters > 0 > cash Flow > change In Working Capital

-5105000

Quarters > 0 > cash Flow > cash From Operations

-32511000

Quarters > 0 > cash Flow > capital Expenditures

11000

Quarters > 0 > cash Flow > cash From Investing

49542000

Quarters > 0 > cash Flow > cash From Financing

14701000

Quarters > 0 > cash Flow > net Change In Cash

31732000

Quarters > 0 > ratios > PE

-0.3378928908873805

Quarters > 0 > ratios > PB

2.648849901060438

Quarters > 0 > ratios > ROE

-60.06896312725256

Quarters > 0 > ratios > ROA

-10.339561865278792

Quarters > 0 > ratios > FCF

-32522000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-9.976073619631903

Quarters > 0 > health Score

17

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

7874000

Quarters > 1 > income Statement > cost Of Revenue

3222000

Quarters > 1 > income Statement > gross Profit

7874000

Quarters > 1 > income Statement > operating Expenses

42012000

Quarters > 1 > income Statement > operating Income

-34138000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-30524000

Quarters > 1 > income Statement > net Income

-30524000

Quarters > 1 > income Statement > eps

-0.3041098305545136

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

100371632

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-30916000

Quarters > 1 > income Statement > operating Margin

-433.55346710693425

Quarters > 1 > income Statement > total Other Income Expense Net

3614000

Quarters > 1 > balance Sheet > cash

44771000

Quarters > 1 > balance Sheet > short Term Investments

262509000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

319178000

Quarters > 1 > balance Sheet > property Plant Equipment

30904000

Quarters > 1 > balance Sheet > total Assets

356422000

Quarters > 1 > balance Sheet > payables

2217000

Quarters > 1 > balance Sheet > short Term Debt

8904000

Quarters > 1 > balance Sheet > long Term Debt

9536000

Quarters > 1 > balance Sheet > total Liabilities

285247000

Quarters > 1 > balance Sheet > equity

71175000

Quarters > 1 > cash Flow > net Income

-30524000

Quarters > 1 > cash Flow > depreciation

3222000

Quarters > 1 > cash Flow > change In Working Capital

-28270000

Quarters > 1 > cash Flow > cash From Operations

-49046000

Quarters > 1 > cash Flow > capital Expenditures

10000

Quarters > 1 > cash Flow > cash From Investing

55722000

Quarters > 1 > cash Flow > cash From Financing

122000

Quarters > 1 > cash Flow > net Change In Cash

6798000

Quarters > 1 > ratios > PE

-0.3041098305545136

Quarters > 1 > ratios > PB

2.1012115445029855

Quarters > 1 > ratios > ROE

-42.885844748858446

Quarters > 1 > ratios > ROA

-8.564005588880597

Quarters > 1 > ratios > FCF

-49056000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-6.230124460248921

Quarters > 1 > health Score

16

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

3674000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

3674000

Quarters > 2 > income Statement > operating Expenses

48369000

Quarters > 2 > income Statement > operating Income

-44695000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-40471000

Quarters > 2 > income Statement > net Income

-40471000

Quarters > 2 > income Statement > eps

-0.40716029062900533

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

99398200

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-42847000

Quarters > 2 > income Statement > operating Margin

-1216.521502449646

Quarters > 2 > income Statement > total Other Income Expense Net

4224000

Quarters > 2 > balance Sheet > cash

37973000

Quarters > 2 > balance Sheet > short Term Investments

316578000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

366650000

Quarters > 2 > balance Sheet > property Plant Equipment

35289000

Quarters > 2 > balance Sheet > total Assets

408303000

Quarters > 2 > balance Sheet > payables

2326000

Quarters > 2 > balance Sheet > short Term Debt

8830000

Quarters > 2 > balance Sheet > long Term Debt

9464000

Quarters > 2 > balance Sheet > total Liabilities

313693000

Quarters > 2 > balance Sheet > equity

94610000

Quarters > 2 > cash Flow > net Income

-40471000

Quarters > 2 > cash Flow > depreciation

1848000

Quarters > 2 > cash Flow > change In Working Capital

-28553000

Quarters > 2 > cash Flow > cash From Operations

-60783000

Quarters > 2 > cash Flow > capital Expenditures

20000

Quarters > 2 > cash Flow > cash From Investing

65735000

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

4952000

Quarters > 2 > ratios > PE

-0.40716029062900533

Quarters > 2 > ratios > PB

1.5654087094387485

Quarters > 2 > ratios > ROE

-42.776662086460206

Quarters > 2 > ratios > ROA

-9.912001626243255

Quarters > 2 > ratios > FCF

-60803000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-16.549537289058247

Quarters > 2 > health Score

16

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

54240000

Quarters > 3 > income Statement > cost Of Revenue

46461000

Quarters > 3 > income Statement > gross Profit

7779000

Quarters > 3 > income Statement > operating Expenses

15028000

Quarters > 3 > income Statement > operating Income

-7249000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-2026000

Quarters > 3 > income Statement > net Income

-2074000

Quarters > 3 > income Statement > eps

-0.021094510976346726

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

98319416

Quarters > 3 > income Statement > income Tax Expense

48000

Quarters > 3 > income Statement > EBITDA

-5171000

Quarters > 3 > income Statement > operating Margin

-13.364675516224189

Quarters > 3 > income Statement > total Other Income Expense Net

5223000

Quarters > 3 > balance Sheet > cash

33021000

Quarters > 3 > balance Sheet > short Term Investments

380376000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

424817000

Quarters > 3 > balance Sheet > property Plant Equipment

37096000

Quarters > 3 > balance Sheet > total Assets

468303000

Quarters > 3 > balance Sheet > payables

2215000

Quarters > 3 > balance Sheet > short Term Debt

8754000

Quarters > 3 > balance Sheet > long Term Debt

9389000

Quarters > 3 > balance Sheet > total Liabilities

341503000

Quarters > 3 > balance Sheet > equity

126800000

Quarters > 3 > cash Flow > net Income

-2073999

Quarters > 3 > cash Flow > depreciation

2077999

Quarters > 3 > cash Flow > change In Working Capital

-62665000

Quarters > 3 > cash Flow > cash From Operations

-55028000

Quarters > 3 > cash Flow > capital Expenditures

173000

Quarters > 3 > cash Flow > cash From Investing

41402000

Quarters > 3 > cash Flow > cash From Financing

9788000

Quarters > 3 > cash Flow > net Change In Cash

-4138000

Quarters > 3 > ratios > PE

-0.021094510976346726

Quarters > 3 > ratios > PB

1.155330676971609

Quarters > 3 > ratios > ROE

-1.635646687697161

Quarters > 3 > ratios > ROA

-0.44287565956229197

Quarters > 3 > ratios > FCF

-55201000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-1.0177175516224188

Quarters > 3 > health Score

20

Valuation > metrics > PE

-0.3378928908873805

Valuation > metrics > PB

2.648849901060438

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-60.06896312725256

Profitability > metrics > ROA

-11.540855901592955

Profitability > metrics > Net Margin

-10.6340490797546

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

4.809623648461325

Risk > metrics > Interest Coverage

-30.402586903799516

Risk > final Score

-116

Risk > verdict

High

Liquidity > metrics > Current Ratio

21.868447874199184

Liquidity > metrics > Quick Ratio

21.868447874199184

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-342

Prev Risks > 1

-69

Prev Risks > 2

9

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:13:02.195Z